Page last updated: 2024-10-28

beta-thujaplicin and Adenocarcinoma

beta-thujaplicin has been researched along with Adenocarcinoma in 2 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, CC2
Chen, BK1
Chen, PH1
Chen, LC1
Li, LH1
Wu, P1
Lee, JY1
Li, PR1
Hsieh, WY1
Ho, CC1
Ho, CL1
Chen, WJ1
Yen, MY1
Yang, SM1
Chen, HW1

Other Studies

2 other studies available for beta-thujaplicin and Adenocarcinoma

ArticleYear
Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.
    Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Epidermal Growth Factor

2020
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Acridine Orange; Adenocarcinoma; Adenocarcinoma of Lung; Annexin A5; Antineoplastic Agents, Phytogen

2014